Reduced glucose consumption in the curly tail mouse does not initiate the pathogenesis leading to spinal neural tube defects.
At embryonic stages of neural tube closure, the mouse embryo exhibits a high rate of glycolysis with glucose as the main energy source. In the curly tail mouse, often used as model system for study of human neural tube defects, a delay in closure of the posterior neuropore (PNP) is proposed to be indirectly caused by a proliferation defect in the caudal region. Because glucose is important for proliferation, we tested glucose uptake in curly tail and control embryos, and in a BALB/c-curly tail recombinant strain. The structure and expression of Glut-1, a glucose transporter molecule that is abundantly present during those embryonic stages and that has been mapped in the region of the major curly tail gene, were also studied; however, no strain differences could be demonstrated. Glucose uptake was determined by measuring glucose depletion from the medium in long-term embryo cultures that encompassed the stages of PNP closure and by measuring accumulation of 3H-deoxyglucose in short-term cultures at the stages of early and final PNP closure. Both approaches indicated a reduced glucose uptake by curly tail and recombinant embryos. Surprisingly, the uptake per cell appeared normal, accompanied by a significantly lower DNA content of the mutant embryos. Therefore, it is unlikely that reduced cell proliferation is caused by a reduction in glucose supply during the pathogenesis of the defects in curly tail embryos. The reduced DNA content as well as the reduced glucose uptake per embryo are likely downstream effects of the aberrant proliferation pattern.
Department of Anatomy and Embryology, Faculty of Medicine, University of Maastricht, NL-6200 MD Maastricht, Netherlands.
M C
MC
Peeters
J L
JL
Geelen
J W
JW
Hekking
N
N
Chavannes
J P
JP
Geraedts
H W
HW
van Straaten
D000818:Animals; D001483:Base Sequence; D018076:DNA, Complementary / Q000032:analysis; D004622:Embryo, Mammalian / Q000378:metabolism*; D005260:Female; D005947:Glucose / Q000172:deficiency / Q000493:pharmacokinetics*; D051272:Glucose Transporter Type 1; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D009004:Monosaccharide Transport Proteins / Q000235:genetics / Q000378:metabolism; D009436:Neural Tube Defects / Q000209:etiology*; D011247:Pregnancy; D013045:Species Specificity
D018076:DNA, Complementary; D051272:Glucose Transporter Type 1; D009004:Monosaccharide Transport Proteins; C495678:Slc2a1 protein, mouse; D005947:Glucose